PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.83%
Negative revenue growth while 2127.T stands at 36.79%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-4.74%
Negative gross profit growth while 2127.T is at 35.71%. Joel Greenblatt would examine cost competitiveness or demand decline.
-11.58%
Negative EBIT growth while 2127.T is at 47.40%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-25.27%
Negative operating income growth while 2127.T is at 46.21%. Joel Greenblatt would press for urgent turnaround measures.
-11.81%
Negative net income growth while 2127.T stands at 54.93%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-11.81%
Negative EPS growth while 2127.T is at 54.85%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-11.81%
Negative diluted EPS growth while 2127.T is at 58.53%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Share reduction while 2127.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
44.88%
10Y revenue/share CAGR under 50% of 2127.T's 356.97%. Michael Burry would suspect a lasting competitive disadvantage.
-7.45%
Negative 5Y CAGR while 2127.T stands at 226.81%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
38.84%
3Y revenue/share CAGR under 50% of 2127.T's 180.31%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
194.01%
Below 50% of 2127.T's 661.18%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
16.46%
Below 50% of 2127.T's 299.84%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
59.57%
Below 50% of 2127.T's 280.03%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
131.98%
Equity/share CAGR of 131.98% while 2127.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
27.65%
Below 50% of 2127.T's 209.58%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
68.35%
3Y equity/share CAGR at 50-75% of 2127.T's 114.36%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-2.78%
Negative 5Y dividend/share CAGR while 2127.T stands at 362.86%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-30.00%
Negative near-term dividend growth while 2127.T invests at 170.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-12.20%
Firm’s AR is declining while 2127.T shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
6.37%
Inventory shrinking or stable vs. 2127.T's 84.37%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
1.87%
Asset growth well under 50% of 2127.T's 20.77%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
5.11%
Under 50% of 2127.T's 15.49%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-6.73%
We’re deleveraging while 2127.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
2.77%
SG&A growth well above 2127.T's 3.52%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.